Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Non-Current Deffered Revenue: 2020-2021

Historic Non-Current Deffered Revenue for Therapeutics (RAPT) over the last 2 years, with Dec 2021 value amounting to $2.1 million.

  • Therapeutics' Non-Current Deffered Revenue fell 88.83% to $241,000 in Q1 2022 from the same period last year, while for Mar 2022 it was $241,000, marking a year-over-year decrease of 88.83%. This contributed to the annual value of $2.1 million for FY2021, which is 1.60% down from last year.
  • Therapeutics' Non-Current Deffered Revenue amounted to $2.1 million in FY2021, which was down 1.60% from $2.2 million recorded in FY2020.
  • Over the past 5 years, Therapeutics' Non-Current Deffered Revenue peaked at $2.2 million during FY2020, and registered a low of $2.1 million during FY2021.
  • Its 2-year average for Non-Current Deffered Revenue is $2.2 million, with a median of $2.2 million in 2020.
  • Data for Therapeutics' Non-Current Deffered Revenue shows a maximum YoY dropped of 1.60% (in 2021) over the last 5 years.
  • Yearly analysis of 2 years shows Therapeutics' Non-Current Deffered Revenue stood at $2.2 million in 2020, then declined by 1.60% to $2.1 million in 2021.